Global Mental Disorders Drugs Market Insights and Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Mental Disorders Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Mental Disorders Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Drugs for Schizophrenia 1.2.3 Antidepressants 1.2.4 Antipsychotics 1.2.5 Anxiolytics 1.2.6 Drugs for the Treatment of Substance and Alcohol Addiction 1.2.7 Drugs for Childhood and Adolescent Mental Illness 1.2.8 Drugs to Treat Cognitive Disorders 1.2.9 Sleep Disorders 1.2.10 Others 1.3 Market by Application 1.3.1 Global Mental Disorders Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Children 1.3.3 Adolescents 1.3.4 Adults 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Mental Disorders Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Mental Disorders Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Mental Disorders Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Mental Disorders Drugs Sales by Region 2.4.1 Global Mental Disorders Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Mental Disorders Drugs by Region (2023-2028) 2.5 Global Mental Disorders Drugs Revenue by Region 2.5.1 Global Mental Disorders Drugs Revenue by Region (2017-2022) 2.5.2 Global Mental Disorders Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Mental Disorders Drugs Sales by Manufacturers 3.1.1 Global Top Mental Disorders Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Mental Disorders Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mental Disorders Drugs in 2021 3.2 Global Mental Disorders Drugs Revenue by Manufacturers 3.2.1 Global Mental Disorders Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Mental Disorders Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Mental Disorders Drugs Revenue in 2021 3.3 Global Mental Disorders Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Mental Disorders Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Mental Disorders Drugs Sales by Type 4.1.1 Global Mental Disorders Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Mental Disorders Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Mental Disorders Drugs Sales Market Share by Type (2017-2028) 4.2 Global Mental Disorders Drugs Revenue by Type 4.2.1 Global Mental Disorders Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Mental Disorders Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Mental Disorders Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Mental Disorders Drugs Price by Type 4.3.1 Global Mental Disorders Drugs Price by Type (2017-2022) 4.3.2 Global Mental Disorders Drugs Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Mental Disorders Drugs Sales by Application 5.1.1 Global Mental Disorders Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Mental Disorders Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Mental Disorders Drugs Sales Market Share by Application (2017-2028) 5.2 Global Mental Disorders Drugs Revenue by Application 5.2.1 Global Mental Disorders Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Mental Disorders Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Mental Disorders Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Mental Disorders Drugs Price by Application 5.3.1 Global Mental Disorders Drugs Price by Application (2017-2022) 5.3.2 Global Mental Disorders Drugs Price Forecast by Application (2023-2028)6 North America 6.1 North America Mental Disorders Drugs Market Size by Type 6.1.1 North America Mental Disorders Drugs Sales by Type (2017-2028) 6.1.2 North America Mental Disorders Drugs Revenue by Type (2017-2028) 6.2 North America Mental Disorders Drugs Market Size by Application 6.2.1 North America Mental Disorders Drugs Sales by Application (2017-2028) 6.2.2 North America Mental Disorders Drugs Revenue by Application (2017-2028) 6.3 North America Mental Disorders Drugs Market Size by Country 6.3.1 North America Mental Disorders Drugs Sales by Country (2017-2028) 6.3.2 North America Mental Disorders Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Mental Disorders Drugs Market Size by Type 7.1.1 Europe Mental Disorders Drugs Sales by Type (2017-2028) 7.1.2 Europe Mental Disorders Drugs Revenue by Type (2017-2028) 7.2 Europe Mental Disorders Drugs Market Size by Application 7.2.1 Europe Mental Disorders Drugs Sales by Application (2017-2028) 7.2.2 Europe Mental Disorders Drugs Revenue by Application (2017-2028) 7.3 Europe Mental Disorders Drugs Market Size by Country 7.3.1 Europe Mental Disorders Drugs Sales by Country (2017-2028) 7.3.2 Europe Mental Disorders Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Mental Disorders Drugs Market Size by Type 8.1.1 Asia Pacific Mental Disorders Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Mental Disorders Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Mental Disorders Drugs Market Size by Application 8.2.1 Asia Pacific Mental Disorders Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Mental Disorders Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Mental Disorders Drugs Market Size by Region 8.3.1 Asia Pacific Mental Disorders Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Mental Disorders Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines9 Latin America 9.1 Latin America Mental Disorders Drugs Market Size by Type 9.1.1 Latin America Mental Disorders Drugs Sales by Type (2017-2028) 9.1.2 Latin America Mental Disorders Drugs Revenue by Type (2017-2028) 9.2 Latin America Mental Disorders Drugs Market Size by Application 9.2.1 Latin America Mental Disorders Drugs Sales by Application (2017-2028) 9.2.2 Latin America Mental Disorders Drugs Revenue by Application (2017-2028) 9.3 Latin America Mental Disorders Drugs Market Size by Country 9.3.1 Latin America Mental Disorders Drugs Sales by Country (2017-2028) 9.3.2 Latin America Mental Disorders Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Mental Disorders Drugs Market Size by Type 10.1.1 Middle East and Africa Mental Disorders Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Mental Disorders Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Mental Disorders Drugs Market Size by Application 10.2.1 Middle East and Africa Mental Disorders Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Mental Disorders Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Mental Disorders Drugs Market Size by Country 10.3.1 Middle East and Africa Mental Disorders Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Mental Disorders Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Corporation Information 11.1.2 Johnson & Johnson Overview 11.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Johnson & Johnson Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Johnson & Johnson Recent Developments 11.2 Pfizer 11.2.1 Pfizer Corporation Information 11.2.2 Pfizer Overview 11.2.3 Pfizer Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Pfizer Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Pfizer Recent Developments 11.3 Eli Lilly 11.3.1 Eli Lilly Corporation Information 11.3.2 Eli Lilly Overview 11.3.3 Eli Lilly Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Eli Lilly Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Eli Lilly Recent Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Corporation Information 11.4.2 GlaxoSmithKline Overview 11.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 GlaxoSmithKline Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 GlaxoSmithKline Recent Developments 11.5 AstraZeneca 11.5.1 AstraZeneca Corporation Information 11.5.2 AstraZeneca Overview 11.5.3 AstraZeneca Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 AstraZeneca Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 AstraZeneca Recent Developments 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Corporation Information 11.6.2 Bristol-Myers Squibb Overview 11.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Bristol-Myers Squibb Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bristol-Myers Squibb Recent Developments 11.7 Abbott Laboratories 11.7.1 Abbott Laboratories Corporation Information 11.7.2 Abbott Laboratories Overview 11.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Abbott Laboratories Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Abbott Laboratories Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Mental Disorders Drugs Industry Chain Analysis 12.2 Mental Disorders Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Mental Disorders Drugs Production Mode & Process 12.4 Mental Disorders Drugs Sales and Marketing 12.4.1 Mental Disorders Drugs Sales Channels 12.4.2 Mental Disorders Drugs Distributors 12.5 Mental Disorders Drugs Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Mental Disorders Drugs Industry Trends 13.2 Mental Disorders Drugs Market Drivers 13.3 Mental Disorders Drugs Market Challenges 13.4 Mental Disorders Drugs Market Restraints14 Key Findings in The Global Mental Disorders Drugs Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer